Leadership

Joe Bayer FCPA GAICD
Executive Chairman

Joe has more than three decades of senior executive experience and has worked for some of the world’s leading consumer and healthcare companies including CSR, Faulding, Mayne Health and Fletcher Building.

Joe has also served as Chief Executive Officer for Kain Corporate & Commercial Lawyers, Chairman of Cynergy Health (Australia) and advised a number of listed and private companies on strategy, capital markets, restructuring and business performance. He is also a Director of Cygenta Capital & Advisory, a private consulting practice.

Joe is a Fellow of CPA Australia and is a Graduate of the Australian Institute of Company Directors. He lives in Adelaide.

Kieran Callan
Chief Executive Officer

Kieran is an international executive who studied Law but decided that the commercial world would offer more diversity and challenge. Kieran has more than three decades of experience in senior management and Chief Executive Officer roles within FMCG businesses with a strong track record of delivering significant and profitable growth. During his diverse career, Kieran was Chief Executive Officer at Joval Group, an international wine and food distribution business where he significantly improved profitability and opened up new international markets. He also held senior management positions at PZ Cussons including Managing Director of Cussons (UK and Australia) and was the founding director of National Australia Bank’s private equity business.

Kieran was a graduate of the first ever Australian Institute of Company Directors CDC course; achieving a Merit assessment. He has facilitated for AICD since 2000 and is a Fellow of the Institute.

Rodney Turner MBT GAICD
Non Executive Director

Rodney comes from a strong clinical & regulatory environment with deep experience in global compliance and technology. He possesses in-depth skills and prior experience in developing product and regulatory strategies for market access and consumer goods such as OTC, medical devices and prescription medicines including many products within the dermatology with senior leadership roles in a diverse range of companies.

Rodney currently runs his own consulting and contracting business and is engaged with a number of well known global and regional Pharmaceutical and Medical Device companies, providing strategic and operational Regulatory Affairs, Quality Management and Compliance direction. Previously, Rodney held positions as Asia-Pacific Head of Regulatory Affairs and Compliance for Sandoz ( one of the largest global generic and biosimilar Pharmaceutical companies) and worked in regional lead roles with iNova Pharmaceuticals, Valeant, Gambro & Fresenius-Kabi Australia.

Rodney lives in Sydney and is a Graduate of Australian Institute of Company Directors.

Ross Andrews
Non Executive Director

Ross has more than 30 years’ corporate advisory experience working with quoted companies, predominately in the UK. He was a main board director of Zeus Capital, the investment bank, until setting up his own consultancy business. He is a member of the Chartered Institute for Securities and Investment and is currently Chairman of standard listed Golden Rock Global plc and Kazai Capital Plc as well as a non-executive director of AIM quoted Integumen plc and Minerva Lending Plc. Ross is also senior adviser to the NEX Exchange and he currently resides in the United Kingdom.